About the Test
Purpose of the test
The purpose of testing for HIV viral load is to measure the amount of viral RNA which is the genetic material of the virus in a small sample of a patient’s blood. This test may be used to diagnose HIV as well as plan and monitor HIV treatment.
Diagnosing HIV
HIV viral load testing is one test that can determine if a person has an HIV infection. There are three types of diagnostic HIV tests: nucleic acid amplification tests (NAATs), antigen/antibody tests, and antibody tests. The HIV viral load test is a type of NAAT test.
Although NAAT testing can determine if a person has been infected within 10 to 33 days after an exposure, it is not routinely used to screen patients without symptoms or exposure to the virus. An HIV viral load test may be ordered to diagnose patients only after a high-risk exposure or when patients are experiencing early symptoms of HIV. This test may also be used to diagnose HIV in infants.
Guiding HIV Treatment
Antiretroviral treatment (ART) is treatment for HIV used to suppress the virus and to prevent HIV from advancing to AIDS. HIV viral load testing is used to guide treatment for patients with HIV by providing information about when to begin ART, which regimen of ART medications may be appropriate, and when to change to a new ART regimen.
Monitoring HIV
HIV viral load testing is used to understand a patient’s response to ART. One goal of ART is to suppress the virus until the patient’s viral load is undetectable, which means it is too low to be detected on an HIV viral load test.
Once a patient begins ART, it usually takes 3 to 6 months for the viral load to reach an undetectable level. When used to monitor treatment, viral load testing is used alongside a CD4 count test, which measures the amount of one type of white blood cell that is destroyed by HIV. Together, these two tests provide information about how well a patient’s treatment is controlling their HIV infection.
What does the test measure?
An HIV viral load test measures the genetic material of the HIV virus, also called RNA. A patient’s HIV viral load describes how many copies of HIV RNA are present in the blood. HIV RNA early detection helps guide treatment as soon as possible.
When a person is initially infected with HIV, the virus begins to replicate and produce more and more copies of itself. CD4 cells are a type of white blood cell that are the main target of HIV. The virus invades CD4 cells and uses them to replicate.
In the early stages of HIV infection, the virus is often present in high amounts even though there may be few, if any, noticeable symptoms. Without treatment, the virus continues to replicate and the viral load increases as the amount of CD4 cells decreases.
Several weeks after infection, the immune system begins to produce HIV antibodies meant to defend against the virus. HIV antibodies temporarily suppress the HIV viral load. Although a person’s initial symptoms may resolve after the production of HIV antibodies, the infection does not go away.
Unless an HIV infection is detected and treated, it may continue to destroy CD4 cells and slowly degrade a person’s immune system. Over time, the immune system can become so weakened that the disease begins to affect the body’s ability to fight infections and certain types of cancer.
When should I get an HIV viral load test?
Diagnostic testing for HIV viral load may be used in patients with a possible or known exposure to the virus who are suspected of having an acute HIV infection. An acute HIV infection describes the earliest stage of HIV infection when some people begin to develop signs and symptoms of this disease. Although up to 60% of people infected will not have symptoms during this period, when they do occur symptoms of an acute HIV infection may include:
- Fever
- Swollen lymph nodes
- Sore throat
- Rash
- Muscle or joint pain
- Diarrhea
- Headache
HIV viral load testing is used in infants born to a person infected with HIV. When and how often infants are tested depends on risk of infection. Infants born to a parent who was effectively treated with ART and maintained an undetectable viral load during pregnancy are considered low risk. Infants born to a parent whose HIV infection wasn’t sufficiently suppressed are considered high risk.
Low-risk infants may be tested for HIV at 2 to 3 weeks of age, then again at 4 to 8 weeks, and finally at 4 to 6 months of age. In high-risk infants, HIV viral load testing may also be performed at birth and at 8 to 10 weeks of age.
When used to guide treatment and monitor HIV, an HIV viral load test is typically ordered when a patient is first diagnosed. After this baseline testing, an HIV viral load test is ordered again when a patient begins ART and at regular intervals thereafter. Several factors can affect this timeline, including a patient’s ability to follow recommended treatment. Generally, HIV viral load testing occurs at the following intervals:
- After an initial diagnosis
- When starting ART
- Within 2 to 4 weeks after starting ART
- Every 4 to 8 weeks until the viral load is suppressed and undetectable
- Once the virus is undetectable, every 3 to 4 months during the first two years of ART
- Every 6 months in some patients who have undetectable viral loads for two years or longer
If a patient changes their ART regimen due to side effects or because their viral load is suppressed, an HIV viral load test may be ordered after 4 to 8 weeks to confirm the effectiveness of the new treatment regimen.
After a patient’s viral load is undetectable on ART, patients may have occasional “blips” in which the viral load becomes detectable again for a short time. Although an isolated “blip” is not a sign that treatment is no longer working, some patients experience more significant increases in viral load that do indicate the HIV infection may have become resistant to ART or that treatment has failed. In patients with a drug-resistant virus, HIV viral load testing may be ordered 4 weeks after beginning a new ART regimen, then at 4 to 8 week intervals until the viral load becomes undetectable.